Synthesis of Naamidine A and Selective Access to N2‑Acyl-2-aminoimidazole Analogues

A short and scalable synthesis of naamidine A, a marine alkaloid with a selective ability to inhibit epidermal growth factor receptor (EGFR)-dependent cellular proliferation, has been achieved. A key achievement in this synthesis was the development of a regioselective hydroamination of a monoprotected propargylguanidine to deliver N3-protected cyclic ene-guanidines. This permits the extension of this methodology to prepare N2-acyl analogues in a fashion that obviates the troublesome acylation of the free 2-aminoimidazoles, which typically yields mixtures of N2- and N2,N2-diacylated products.